Detalhe da pesquisa
1.
Neoantigen landscape dynamics during human melanoma-T cell interactions.
Nature
; 536(7614): 91-5, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27350335
2.
Simplified Monopalmitoyl Toll-like Receptor 2 Ligand Mini-UPam for Self-Adjuvanting Neoantigen-Based Synthetic Cancer Vaccines.
Chembiochem
; 22(7): 1215-1222, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33180981
3.
The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells.
Int J Mol Sci
; 23(1)2021 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008560
4.
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.
Cancer Immunol Immunother
; 66(7): 913-926, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28401257
5.
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.
Cancer Immunol Immunother
; 65(12): 1451-1463, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619514
6.
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Cancer Immunol Res
; 12(3): 334-349, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194598
7.
Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-ß.
Cytokine
; 61(2): 645-55, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23299081
8.
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792124
9.
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer.
J Immunother Cancer
; 11(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949617
10.
Neoantigen Targetability in Progressive Advanced Melanoma.
Clin Cancer Res
; 29(20): 4278-4288, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540567
11.
A library of cancer testis specific T cell receptors for T cell receptor gene therapy.
Mol Ther Oncolytics
; 28: 1-14, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36589698
12.
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.
Front Immunol
; 14: 1121973, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026005
13.
Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy.
Mol Ther Oncolytics
; 31: 100738, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920174
14.
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
Cancer Immunol Immunother
; 60(7): 953-63, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21431917
15.
Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial.
BMJ Open
; 10(11): e044036, 2020 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234662
16.
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33427690
17.
Targeting of the Cancer-Associated Fibroblast-T-Cell Axis in Solid Malignancies.
J Clin Med
; 8(11)2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31731701
18.
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors.
Cancer Immunol Res
; 7(1): 6-11, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425107
19.
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
Genome Med
; 11(1): 87, 2019 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888734
20.
Identification of non-mutated neoantigens presented by TAP-deficient tumors.
J Exp Med
; 215(9): 2325-2337, 2018 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115740